These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7977649)
1. Bcl-2 protein expression and long-term survival in breast cancer. Joensuu H; Pylkkänen L; Toikkanen S Am J Pathol; 1994 Nov; 145(5):1191-8. PubMed ID: 7977649 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
3. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. Lipponen P; Pietiläinen T; Kosma VM; Aaltomaa S; Eskelinen M; Syrjänen K J Pathol; 1995 Sep; 177(1):49-55. PubMed ID: 7472779 [TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up. el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973 [TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein has no independent prognostic value in breast cancer. Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383 [TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer. Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314 [TBL] [Abstract][Full Text] [Related]
11. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors. Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Bella MA; Cocconi G Cancer; 1999 Aug; 87(4):224-30. PubMed ID: 10455211 [TBL] [Abstract][Full Text] [Related]
12. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084 [TBL] [Abstract][Full Text] [Related]
13. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis. Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599 [TBL] [Abstract][Full Text] [Related]
14. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients? Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882 [TBL] [Abstract][Full Text] [Related]
15. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273 [TBL] [Abstract][Full Text] [Related]
16. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]
17. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. Yu H; Levesque MA; Clark GM; Diamandis EP Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341 [TBL] [Abstract][Full Text] [Related]
19. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Sinicrope FA; Hart J; Michelassi F; Lee JJ Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]